Loading...
Loading...
Janney Capital initiated coverage on
Aldeyra Therapeutics IncALDX with a Buy rating.
The target price for Aldeyra Therapeutics is set to $13.
Aldeyra Therapeutics shares have gained 11.53 percent over the past 52 weeks, while the S&P 500 index has surged 10.18 percent in the same period.
Aldeyra Therapeutics' shares dropped 3.65 percent to close at $6.87 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in